Loading clinical trials...
Loading clinical trials...
Phase II Study Evaluating the Toxicity and Efficacy of a Modified German Paediatric Hodgkin's Lymphoma Protocol (HD95) in Young Adults (Aged 18-30 Years) With Hodgkin's Lymphoma
Conditions
Interventions
cyclophosphamide
doxorubicin hydrochloride
+5 more
Locations
5
United Kingdom
Leeds Cancer Centre at St. James's University Hospital
Leeds, England, United Kingdom
University College Hospital - London
London, England, United Kingdom
King's College Hospital
London, England, United Kingdom
Northern Centre for Cancer Treatment at Newcastle General Hospital
Newcastle upon Tyne, England, United Kingdom
Mount Vernon Cancer Centre at Mount Vernon Hospital
Northwood, England, United Kingdom
Start Date
March 1, 2008
Primary Completion Date
September 1, 2012
Completion Date
September 1, 2012
Last Updated
December 4, 2014
NCT07388563
NCT06337318
NCT05529069
NCT05139017
NCT06263491
NCT07350863
Lead Sponsor
University College, London
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions